Dr. Stemmer-Rachamimov is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
WRN 3
Boston, MA 02114Phone+1 617-726-5510Fax+1 617-724-1813
Education & Training
Massachusetts General HospitalFellowship, Neuropathology, 1999 - 2001
University of Milan Faculty of MedicineClass of 1982
Certifications & Licensure
MA State Medical License 1995 - 2026- American Board of Pathology Anatomic Pathology
- American Board of Pathology Neuropathology
Publications & Presentations
PubMed
- Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis type 1 (NF1).Calixto-Hope G Lucas, Andrea M Gross, Carlos G Romo, Carina A Dehner, Alexander J Lazar
Neuro-Oncology. 2024-11-06 - 1 citationsClinical utility of a blood based assay for the detection of IDH1.R132H-mutant gliomas.Syeda Maheen Batool, Ana K Escobedo, Tiffaney Hsia, Emil Ekanayake, Sirena K Khanna
Nature Communications. 2024-08-16 - Reply to L. Lucchino et al. on commentary on "Histologic correlates of "Choroidal Abnormalities" in Neurofibromatosis type 1".Anat O Stemmer-Rachamimov, Liana Kozanno, Scott R Plotkin, Justin T Jordan, Joseph F Rizzo 3rd
Acta Neuropathologica. 2024-08-16
Press Mentions
Antiangiogenesis Treatment Improves Hearing in Some NF2 PatientsJuly 8th, 2009
Grant Support
- Neuropathology CoreNational Institute Of Neurological Disorders And Stroke2008–2012
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
